BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sancho-Albero M, Navascués N, Mendoza G, Sebastián V, Arruebo M, Martín-Duque P, Santamaría J. Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells. J Nanobiotechnology 2019;17:16. [PMID: 30683120 DOI: 10.1186/s12951-018-0437-z] [Cited by in Crossref: 66] [Cited by in F6Publishing: 94] [Article Influence: 22.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Tian L, Lu J, Ng IO. Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis 2022;11. [DOI: 10.1038/s41389-022-00431-5] [Reference Citation Analysis]
2 Hamzah R, Alghazali K, Biris A, Griffin RJ. Nanoparticle-Labeled Exosomes as Theranostic Agents: A Review. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01426] [Reference Citation Analysis]
3 Wang Z, Mo H, He Z, Chen A, Cheng P. Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advances. Biomedicine & Pharmacotherapy 2022;153:113480. [DOI: 10.1016/j.biopha.2022.113480] [Reference Citation Analysis]
4 Piao L, Na OH, Seo EH, Hong SW, Sohn KM, Kwon Y, Lee SH, Kim SH. Effects of general anaesthesia with an inhalational anaesthetic agent on the expression of exosomes in rats. Int J Med Sci 2022;19:1399-407. [PMID: 36035371 DOI: 10.7150/ijms.72565] [Reference Citation Analysis]
5 Borzdziłowska P, Bednarek I. Alpha Mangostin and Cisplatin as Modulators of Exosomal Interaction of Ovarian Cancer Cell with Fibroblasts. IJMS 2022;23:8913. [DOI: 10.3390/ijms23168913] [Reference Citation Analysis]
6 Gomes P, Tzouanou F, Skolariki K, Iakovou AV, Noguera-Ortiz C, Tsirtsaki K, Waites CL, Vlamos P, Sousa N, Costa-Silva B, Kapogiannis D, Sotiropoulos I. Extracellular vesicles and Alzheimer's disease in the novel era of Precision Medicine: Implications for disease progression, diagnosis and treatment. Exp Neurol 2022;:114183. [PMID: 35952764 DOI: 10.1016/j.expneurol.2022.114183] [Reference Citation Analysis]
7 Bonet-aleta J, Sancho-albero M, Calzada-funes J, Irusta S, Martin-duque P, Hueso JL, Santamaria J. Glutathione-Triggered catalytic response of Copper-Iron mixed oxide Nanoparticles. Leveraging tumor microenvironment conditions for chemodynamic therapy. Journal of Colloid and Interface Science 2022;617:704-17. [DOI: 10.1016/j.jcis.2022.03.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Khosravi N, Pishavar E, Baradaran B, Oroojalian F, Mokhtarzadeh A. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics. J Control Release 2022;348:706-22. [PMID: 35732250 DOI: 10.1016/j.jconrel.2022.06.026] [Reference Citation Analysis]
9 Ginini L, Billan S, Fridman E, Gil Z. Insight into Extracellular Vesicle-Cell Communication: From Cell Recognition to Intracellular Fate. Cells 2022;11:1375. [DOI: 10.3390/cells11091375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Loch-Neckel G, Matos AT, Vaz AR, Brites D. Challenges in the Development of Drug Delivery Systems Based on Small Extracellular Vesicles for Therapy of Brain Diseases. Front Pharmacol 2022;13:839790. [PMID: 35422699 DOI: 10.3389/fphar.2022.839790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Quesnel A, Broughton A, Karagiannis GS, Filippou PS. Message in the bottle: regulation of the tumor microenvironment via exosome-driven proteolysis. Cancer Metastasis Rev 2022. [PMID: 35394580 DOI: 10.1007/s10555-022-10030-w] [Reference Citation Analysis]
12 Choi H, Choi K, Kim D, Oh B, Yim H, Jo S, Choi C. Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges. Pharmaceutics 2022;14:672. [DOI: 10.3390/pharmaceutics14030672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Sancho-Albero M, Encinas-Giménez M, Sebastián V, Pérez E, Luján L, Santamaría J, Martin-Duque P. Transfer of photothermal nanoparticles using stem cell derived small extracellular vesicles for in vivo treatment of primary and multinodular tumours. J Extracell Vesicles 2022;11:e12193. [PMID: 35257503 DOI: 10.1002/jev2.12193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ivanova E, Khan S. How Various Drug Delivery Methods Could Aid in the Translation of Genome Prime Editing Technologies. Genetics Research 2022;2022:1-8. [DOI: 10.1155/2022/7301825] [Reference Citation Analysis]
15 Thomas SC, Kim JW, Pauletti GM, Hassett DJ, Kotagiri N. Exosomes: Biological Pharmaceutical Nanovectors for Theranostics. Front Bioeng Biotechnol 2021;9:808614. [PMID: 35096795 DOI: 10.3389/fbioe.2021.808614] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Filipović L, Kojadinović M, Popović M. Exosomes and exosome-mimetics as targeted drug carriers: Where we stand and what the future holds? Journal of Drug Delivery Science and Technology 2022;68:103057. [DOI: 10.1016/j.jddst.2021.103057] [Reference Citation Analysis]
17 Nik Mohamed Kamal NNS, Shahidan WNS. Salivary Exosomes: From Waste to Promising Periodontitis Treatment. Front Physiol 2021;12:798682. [PMID: 35069258 DOI: 10.3389/fphys.2021.798682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hu M, Cao Z, Jiang D. The Effect of miRNA-Modified Exosomes in Animal Models of Spinal Cord Injury: A meta-Analysis. Front Bioeng Biotechnol 2021;9:819651. [PMID: 35071220 DOI: 10.3389/fbioe.2021.819651] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Chowdhury SG, Ray R, Bhattacharya D, Karmakar P. DNA damage induced cellular senescence and it’s PTEN-armed exosomes—the warriors against prostate carcinoma cells. Med Oncol 2022;39. [DOI: 10.1007/s12032-021-01614-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Chan MH, Chang ZX, Huang CF, Lee LJ, Liu RS, Hsiao M. Integrated therapy platform of exosomal system: hybrid inorganic/organic nanoparticles with exosomes for cancer treatment. Nanoscale Horiz 2022. [PMID: 35043812 DOI: 10.1039/d1nh00637a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Wang R, Wang X, Zhang Y, Zhao H, Cui J, Li J, Di L. Emerging prospects of extracellular vesicles for brain disease theranostics. Journal of Controlled Release 2022;341:844-68. [DOI: 10.1016/j.jconrel.2021.12.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Thakur A, Parra DC, Motallebnejad P, Brocchi M, Chen HJ. Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics. Bioact Mater 2022;10:281-94. [PMID: 34901546 DOI: 10.1016/j.bioactmat.2021.08.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 23.0] [Reference Citation Analysis]
23 Karagyaur M, Dzhauari S, Basalova N, Aleksandrushkina N, Sagaradze G, Danilova N, Malkov P, Popov V, Skryabina M, Efimenko A, Tkachuk V. MSC Secretome as a Promising Tool for Neuroprotection and Neuroregeneration in a Model of Intracerebral Hemorrhage. Pharmaceutics 2021;13:2031. [PMID: 34959314 DOI: 10.3390/pharmaceutics13122031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Wang Y, Wang W, Kong F, Zhang Q, Xiao J, Zhang Y, Yan B. Tango of dual nanoparticles: Interplays between exosomes and nanomedicine. Bioeng Transl Med. [DOI: 10.1002/btm2.10269] [Reference Citation Analysis]
25 Guo Y, Wang H, Huang L, Ou L, Zhu J, Liu S, Xu X. Small extracellular vesicles-based cell-free strategies for therapy. MedComm (2020) 2021;2:17-26. [PMID: 34766134 DOI: 10.1002/mco2.57] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Oshchepkova A, Markov O, Evtushenko E, Chernonosov A, Kiseleva E, Morozova K, Matveeva V, Artemyeva L, Vlassov V, Zenkova M. Tropism of Extracellular Vesicles and Cell-Derived Nanovesicles to Normal and Cancer Cells: New Perspectives in Tumor-Targeted Nucleic Acid Delivery. Pharmaceutics 2021;13:1911. [PMID: 34834326 DOI: 10.3390/pharmaceutics13111911] [Reference Citation Analysis]
27 Lara P, Huis In 't Veld RV, Jorquera-Cordero C, Chan AB, Ossendorp F, Cruz LJ. Zinc-Phthalocyanine-Loaded Extracellular Vesicles Increase Efficacy and Selectivity of Photodynamic Therapy in Co-Culture and Preclinical Models of Colon Cancer. Pharmaceutics 2021;13:1547. [PMID: 34683840 DOI: 10.3390/pharmaceutics13101547] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Jurgielewicz B, Stice S, Yao Y. Therapeutic Potential of Nucleic Acids when Combined with Extracellular Vesicles. Aging Dis 2021;12:1476-93. [PMID: 34527423 DOI: 10.14336/AD.2021.0708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Malik S, Saltzman WM, Bahal R. Extracellular vesicles mediated exocytosis of antisense peptide nucleic acids. Mol Ther Nucleic Acids 2021;25:302-15. [PMID: 34458012 DOI: 10.1016/j.omtn.2021.07.018] [Reference Citation Analysis]
30 Vásquez X, Sánchez-Gómez P, Palma V. Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime? Int J Mol Sci 2021;22:8248. [PMID: 34361013 DOI: 10.3390/ijms22158248] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Sharma S, Masud MK, Kaneti YV, Rewatkar P, Koradia A, Hossain MSA, Yamauchi Y, Popat A, Salomon C. Extracellular Vesicle Nanoarchitectonics for Novel Drug Delivery Applications. Small 2021;:e2102220. [PMID: 34216426 DOI: 10.1002/smll.202102220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
32 Kwon SH, Faruque HA, Kee H, Kim E, Park S. Exosome-based hybrid nanostructures for enhanced tumor targeting and hyperthermia therapy. Colloids Surf B Biointerfaces 2021;205:111915. [PMID: 34130212 DOI: 10.1016/j.colsurfb.2021.111915] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Hamzah RN, Alghazali KM, Biris AS, Griffin RJ. Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk. Int J Mol Sci 2021;22:5346. [PMID: 34069542 DOI: 10.3390/ijms22105346] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
34 Kaban K, Hinterleitner C, Zhou Y, Salva E, Kantarci AG, Salih HR, Märklin M. Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer. Cancers (Basel) 2021;13:2397. [PMID: 34063475 DOI: 10.3390/cancers13102397] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
35 Giacobino C, Canta M, Fornaguera C, Borrós S, Cauda V. Extracellular Vesicles and Their Current Role in Cancer Immunotherapy. Cancers (Basel) 2021;13:2280. [PMID: 34068657 DOI: 10.3390/cancers13092280] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
36 Perocheau D, Touramanidou L, Gurung S, Gissen P, Baruteau J. Clinical applications for exosomes: Are we there yet? Br J Pharmacol 2021;178:2375-92. [PMID: 33751579 DOI: 10.1111/bph.15432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Emam SE, Elsadek NE, Abu Lila AS, Takata H, Kawaguchi Y, Shimizu T, Ando H, Ishima Y, Ishida T. Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice. J Control Release 2021;334:327-34. [PMID: 33957196 DOI: 10.1016/j.jconrel.2021.05.001] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
38 Qiu Y, Li P, Zhang Z, Wu M. Insights Into Exosomal Non-Coding RNAs Sorting Mechanism and Clinical Application. Front Oncol 2021;11:664904. [PMID: 33987099 DOI: 10.3389/fonc.2021.664904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Jafari D, Shajari S, Jafari R, Mardi N, Gomari H, Ganji F, Forouzandeh Moghadam M, Samadikuchaksaraei A. Designer Exosomes: A New Platform for Biotechnology Therapeutics. BioDrugs 2020;34:567-86. [PMID: 32754790 DOI: 10.1007/s40259-020-00434-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 52] [Article Influence: 30.0] [Reference Citation Analysis]
40 Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 2021;19:47. [PMID: 33892745 DOI: 10.1186/s12964-021-00730-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 108] [Article Influence: 14.0] [Reference Citation Analysis]
41 Kwok ZH, Ni K, Jin Y. Extracellular Vesicle Associated Non-Coding RNAs in Lung Infections and Injury. Cells 2021;10:965. [PMID: 33919158 DOI: 10.3390/cells10050965] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
42 Jouida A, McCarthy C, Fabre A, Keane MP. Exosomes: a new perspective in EGFR-mutated lung cancer. Cancer Metastasis Rev 2021;40:589-601. [PMID: 33855679 DOI: 10.1007/s10555-021-09962-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Almohammai A, Rahbarghazi R, Keyhanmanesh R, Rezaie J, Ahmadi M. Asthmatic condition induced the activity of exosome secretory pathway in rat pulmonary tissues. J Inflamm (Lond) 2021;18:14. [PMID: 33794910 DOI: 10.1186/s12950-021-00275-7] [Reference Citation Analysis]
44 Gaurav I, Thakur A, Iyaswamy A, Wang X, Chen X, Yang Z. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems. Molecules 2021;26:1544. [PMID: 33799765 DOI: 10.3390/molecules26061544] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
45 Xu P, Ma Y, Wu H, Wang YL. Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy. Front Cell Dev Biol 2021;9:646326. [PMID: 33777951 DOI: 10.3389/fcell.2021.646326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
46 Dong X, Lei Y, Yu Z, Wang T, Liu Y, Han G, Zhang X, Li Y, Song Y, Xu H, Du M, Yin H, Wang X, Yan H. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis. Theranostics 2021;11:5107-26. [PMID: 33859737 DOI: 10.7150/thno.54755] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
47 Barjesteh T, Mansur S, Bao Y. Inorganic Nanoparticle-Loaded Exosomes for Biomedical Applications. Molecules 2021;26:1135. [PMID: 33672706 DOI: 10.3390/molecules26041135] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
48 Mao Y, Jacob V, Singal A, Lei S, Park MS, Lima MRN, Li C, Dhall S, Sathyamoorthy M, Kohn J. Exosomes Secreted from Amniotic Membrane Contribute to Its Anti-Fibrotic Activity. Int J Mol Sci 2021;22:2055. [PMID: 33669673 DOI: 10.3390/ijms22042055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Tan PPS, Hall D, Chilian WM, Chia YC, Mohd Zain S, Lim HM, Kumar DN, Ching SM, Low TY, Md Noh MF, Pung YF. Exosomal microRNAs in the development of essential hypertension and its potential as biomarkers. Am J Physiol Heart Circ Physiol 2021;320:H1486-97. [PMID: 33577433 DOI: 10.1152/ajpheart.00888.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
50 Jasiewicz N, Drabenstott C, Nguyen J. Harnessing the full potential of extracellular vesicles as drug carriers. Current Opinion in Colloid & Interface Science 2021;51:101412. [DOI: 10.1016/j.cocis.2020.101412] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
51 Kwok ZH, Wang C, Jin Y. Extracellular Vesicle Transportation and Uptake by Recipient Cells: A Critical Process to Regulate Human Diseases. Processes (Basel) 2021;9:273. [PMID: 34336602 DOI: 10.3390/pr9020273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Suh JH, Joo HS, Hong EB, Lee HJ, Lee JM. Therapeutic Application of Exosomes in Inflammatory Diseases. Int J Mol Sci 2021;22:1144. [PMID: 33498928 DOI: 10.3390/ijms22031144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
53 Domínguez-Arca V, Costa RR, Carvalho AM, Taboada P, Reis RL, Prieto G, Pashkuleva I. Liposomes embedded in layer by layer constructs as simplistic extracellular vesicles transfer model. Mater Sci Eng C Mater Biol Appl 2021;121:111813. [PMID: 33579457 DOI: 10.1016/j.msec.2020.111813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Aengenheister L, Favaro RR, Morales-Prieto DM, Furer LA, Gruber M, Wadsack C, Markert UR, Buerki-Thurnherr T. Research on nanoparticles in human perfused placenta: State of the art and perspectives. Placenta 2021;104:199-207. [PMID: 33418345 DOI: 10.1016/j.placenta.2020.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
55 Zhang M, Du Y, Wang S, Chen B. A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes. Drug Des Devel Ther 2020;14:5495-503. [PMID: 33363358 DOI: 10.2147/DDDT.S282368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
56 Fathi P, Rao L, Chen X. Extracellular vesicle‐coated nanoparticles. View 2021;2:20200187. [DOI: 10.1002/viw.20200187] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
57 Tanziela T, Shaikh S, Jiang H, Lu Z, Wang X. Efficient encapsulation of biocompatible nanoparticles in exosomes for cancer theranostics. Nano Today 2020;35:100964. [DOI: 10.1016/j.nantod.2020.100964] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
58 Sebastian V, Sancho-Albero M, Arruebo M, Pérez-López AM, Rubio-Ruiz B, Martin-Duque P, Unciti-Broceta A, Santamaría J. Nondestructive production of exosomes loaded with ultrathin palladium nanosheets for targeted bio-orthogonal catalysis. Nat Protoc 2021;16:131-63. [PMID: 33247282 DOI: 10.1038/s41596-020-00406-z] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
59 Grenier-Pleau I, Tyryshkin K, Le TD, Rudan J, Bonneil E, Thibault P, Zeng K, Lässer C, Mallinson D, Lamprou D, Hui J, Postovit LM, Chan EYW, Abraham SA. Blood extracellular vesicles from healthy individuals regulate hematopoietic stem cells as humans age. Aging Cell 2020;19:e13245. [PMID: 33029858 DOI: 10.1111/acel.13245] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
60 Vaidya M, Sugaya K. DNA Associated with Circulating Exosomes as a Biomarker for Glioma. Genes (Basel) 2020;11:E1276. [PMID: 33137926 DOI: 10.3390/genes11111276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Palazzolo S, Memeo L, Hadla M, Duzagac F, Steffan A, Perin T, Canzonieri V, Tuccinardi T, Caligiuri I, Rizzolio F. Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools. Cancers (Basel) 2020;12:E3165. [PMID: 33126572 DOI: 10.3390/cancers12113165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
62 Racca L, Cauda V. Remotely Activated Nanoparticles for Anticancer Therapy. Nanomicro Lett 2020;13:11. [PMID: 34138198 DOI: 10.1007/s40820-020-00537-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
63 Lara P, Chan AB, Cruz LJ, Quest AFG, Kogan MJ. Exploiting the Natural Properties of Extracellular Vesicles in Targeted Delivery towards Specific Cells and Tissues. Pharmaceutics 2020;12:E1022. [PMID: 33114492 DOI: 10.3390/pharmaceutics12111022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
64 Sancho-Albero M, Sebastián V, Sesé J, Pazo-Cid R, Mendoza G, Arruebo M, Martín-Duque P, Santamaría J. Isolation of exosomes from whole blood by a new microfluidic device: proof of concept application in the diagnosis and monitoring of pancreatic cancer. J Nanobiotechnology 2020;18:150. [PMID: 33092584 DOI: 10.1186/s12951-020-00701-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
65 Kostyushev D, Kostyusheva A, Brezgin S, Smirnov V, Volchkova E, Lukashev A, Chulanov V. Gene Editing by Extracellular Vesicles. Int J Mol Sci 2020;21:E7362. [PMID: 33028045 DOI: 10.3390/ijms21197362] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
66 Lu X, Zhang Y, Xie G, Ding Y, Cong H, Xuan S. Exosomal non‑coding RNAs: Novel biomarkers with emerging clinical applications in gastric cancer (Review). Mol Med Rep 2020;22:4091-100. [PMID: 33000279 DOI: 10.3892/mmr.2020.11519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Liu J, Wu F, Zhou H. Macrophage-derived exosomes in cancers: Biogenesis, functions and therapeutic applications. Immunol Lett 2020;227:102-8. [PMID: 32888974 DOI: 10.1016/j.imlet.2020.08.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
68 Rahmani A, Saleki K, Javanmehr N, Khodaparast J, Saadat P, Nouri HR. Mesenchymal stem cell-derived extracellular vesicle-based therapies protect against coupled degeneration of the central nervous and vascular systems in stroke. Ageing Res Rev 2020;62:101106. [PMID: 32565329 DOI: 10.1016/j.arr.2020.101106] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
69 Jurgielewicz BJ, Yao Y, Stice SL. Kinetics and Specificity of HEK293T Extracellular Vesicle Uptake using Imaging Flow Cytometry. Nanoscale Res Lett 2020;15:170. [PMID: 32833066 DOI: 10.1186/s11671-020-03399-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
70 Cabeza L, Perazzoli G, Peña M, Cepero A, Luque C, Melguizo C, Prados J. Cancer therapy based on extracellular vesicles as drug delivery vehicles. J Control Release 2020;327:296-315. [PMID: 32814093 DOI: 10.1016/j.jconrel.2020.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
71 Bheri S, Hoffman JR, Park HJ, Davis ME. Biomimetic nanovesicle design for cardiac tissue repair. Nanomedicine (Lond) 2020;15:1873-96. [PMID: 32752925 DOI: 10.2217/nnm-2020-0097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
72 Mitsis T, Pierouli K, Diakou KL, Papakonstantinou E, Bacopoulou F, Chrousos GP, Vlachakis D. Exosomics. EMBnet J 2020;26:e934. [PMID: 32832420 DOI: 10.14806/ej.26.0.934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
73 Giassafaki LN, Siqueira S, Panteris E, Psatha K, Chatzopoulou F, Aivaliotis M, Tzimagiorgis G, Müllertz A, Fatouros DG, Vizirianakis IS. Towards analyzing the potential of exosomes to deliver microRNA therapeutics. J Cell Physiol 2021;236:1529-44. [PMID: 32749687 DOI: 10.1002/jcp.29991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
74 Zocchi MR, Tosetti F, Benelli R, Poggi A. Cancer Nanomedicine Special Issue Review Anticancer Drug Delivery with Nanoparticles: Extracellular Vesicles or Synthetic Nanobeads as Therapeutic Tools for Conventional Treatment or Immunotherapy. Cancers (Basel) 2020;12:E1886. [PMID: 32668783 DOI: 10.3390/cancers12071886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
75 Dugershaw BB, Aengenheister L, Hansen SSK, Hougaard KS, Buerki-Thurnherr T. Recent insights on indirect mechanisms in developmental toxicity of nanomaterials. Part Fibre Toxicol 2020;17:31. [PMID: 32653006 DOI: 10.1186/s12989-020-00359-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
76 Kreyling WG, Holzwarth U, Hirn S, Schleh C, Wenk A, Schäffler M, Haberl N, Gibson N. Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm silver nanoparticle aerosols in healthy adult rats after a single 1½-hour inhalation exposure. Part Fibre Toxicol 2020;17:21. [PMID: 32503677 DOI: 10.1186/s12989-020-00347-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
77 Park J, Lee H, Youn YS, Oh KT, Lee ES. Tumor-Homing pH-Sensitive Extracellular Vesicles for Targeting Heterogeneous Tumors. Pharmaceutics 2020;12:E372. [PMID: 32316679 DOI: 10.3390/pharmaceutics12040372] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
78 Wathoni N, Rusdin A, Motoyama K, Joni IM, Lesmana R, Muchtaridi M. Nanoparticle Drug Delivery Systems for α-Mangostin. Nanotechnol Sci Appl 2020;13:23-36. [PMID: 32280205 DOI: 10.2147/NSA.S243017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
79 Moertl S, Buschmann D, Azimzadeh O, Schneider M, Kell R, Winkler K, Tapio S, Hornhardt S, Merl-Pham J, Pfaffl MW, Atkinson MJ. Radiation Exposure of Peripheral Mononuclear Blood Cells Alters the Composition and Function of Secreted Extracellular Vesicles. Int J Mol Sci 2020;21:E2336. [PMID: 32230970 DOI: 10.3390/ijms21072336] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
80 Lara P, Palma-Florez S, Salas-Huenuleo E, Polakovicova I, Guerrero S, Lobos-Gonzalez L, Campos A, Muñoz L, Jorquera-Cordero C, Varas-Godoy M, Cancino J, Arias E, Villegas J, Cruz LJ, Albericio F, Araya E, Corvalan AH, Quest AFG, Kogan MJ. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors. J Nanobiotechnology 2020;18:20. [PMID: 31973696 DOI: 10.1186/s12951-020-0573-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
81 Rayamajhi S, Marasini R, Nguyen TDT, Plattner BL, Biller D, Aryal S. Strategic reconstruction of macrophage-derived extracellular vesicles as a magnetic resonance imaging contrast agent. Biomater Sci 2020;8:2887-904. [DOI: 10.1039/d0bm00128g] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
82 Sancho-albero M, Medel-martínez A, Martín-duque P. Use of exosomes as vectors to carry advanced therapies. RSC Adv 2020;10:23975-87. [DOI: 10.1039/d0ra02414g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
83 Ou Y, Zou S, Goh WJ, Chong SY, Venkatesan G, Wacker MG, Storm G, Wang J, Czarny B, Pastorin G, Woon ECY. Micro cell vesicle technology (mCVT): a novel hybrid system of gene delivery for hard-to-transfect (HTT) cells. Nanoscale 2020;12:18022-30. [DOI: 10.1039/d0nr03784b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
84 Susa F, Limongi T, Dumontel B, Vighetto V, Cauda V. Engineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine. Cancers (Basel) 2019;11:E1979. [PMID: 31835327 DOI: 10.3390/cancers11121979] [Cited by in Crossref: 25] [Cited by in F6Publishing: 35] [Article Influence: 8.3] [Reference Citation Analysis]
85 Szatmári T, Hargitai R, Sáfrány G, Lumniczky K. Extracellular Vesicles in Modifying the Effects of Ionizing Radiation. Int J Mol Sci 2019;20:E5527. [PMID: 31698689 DOI: 10.3390/ijms20225527] [Cited by in Crossref: 10] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
86 Villa F, Quarto R, Tasso R. Extracellular Vesicles as Natural, Safe and Efficient Drug Delivery Systems. Pharmaceutics. 2019;11. [PMID: 31661862 DOI: 10.3390/pharmaceutics11110557] [Cited by in Crossref: 42] [Cited by in F6Publishing: 51] [Article Influence: 14.0] [Reference Citation Analysis]
87 Jaquenod De Giusti C, Santalla M, Das S. Exosomal non-coding RNAs (Exo-ncRNAs) in cardiovascular health. J Mol Cell Cardiol 2019;137:143-51. [PMID: 31669445 DOI: 10.1016/j.yjmcc.2019.09.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
88 Sancho-Albero M, Rubio-Ruiz B, Pérez-López AM, Sebastián V, Martín-Duque P, Arruebo M, Santamaría J, Unciti-Broceta A. Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis. Nat Catal 2019;2:864-72. [PMID: 31620674 DOI: 10.1038/s41929-019-0333-4] [Cited by in Crossref: 71] [Cited by in F6Publishing: 115] [Article Influence: 23.7] [Reference Citation Analysis]
89 Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding X, Qiang L, Li G, Han Z, Yuan Y, Gao S. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy. J Nanobiotechnology 2019;17:93. [PMID: 31481080 DOI: 10.1186/s12951-019-0526-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 102] [Article Influence: 16.0] [Reference Citation Analysis]
90 Roma-Rodrigues C, Pombo I, Raposo L, Pedrosa P, Fernandes AR, Baptista PV. Nanotheranostics Targeting the Tumor Microenvironment. Front Bioeng Biotechnol 2019;7:197. [PMID: 31475143 DOI: 10.3389/fbioe.2019.00197] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
91 Lin Y, Lu Y, Li X. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents. J Drug Target 2020;28:129-41. [PMID: 31280623 DOI: 10.1080/1061186X.2019.1641508] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
92 Lee DS, Suh M, Kang SY, Hwang DW. Physiologic constraints of using exosomes in vivo as systemic delivery vehicles. PRNANO 2019;2:344-69. [DOI: 10.33218/prnano2(3)070819.1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
93 Mansoor H, Ong HS, Riau AK, Stanzel TP, Mehta JS, Yam GH. Current Trends and Future Perspective of Mesenchymal Stem Cells and Exosomes in Corneal Diseases. Int J Mol Sci. 2019;20. [PMID: 31212734 DOI: 10.3390/ijms20122853] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
94 Sancho-albero M, Encabo-berzosa MDM, Beltrán-visiedo M, Fernández-messina L, Sebastián V, Sánchez-madrid F, Arruebo M, Santamaría J, Martín-duque P. Efficient encapsulation of theranostic nanoparticles in cell-derived exosomes: leveraging the exosomal biogenesis pathway to obtain hollow gold nanoparticle-hybrids. Nanoscale 2019;11:18825-36. [DOI: 10.1039/c9nr06183e] [Cited by in Crossref: 31] [Cited by in F6Publishing: 47] [Article Influence: 10.3] [Reference Citation Analysis]